That's 25c/day at normal oral doses. 2.5c/day sublingually.
TAU - still waiting on delivery. I've seen different figures mentioned, but no personal experience with it yet.
Edited by MrHappy, 04 December 2011 - 10:59 PM.
Posted 04 December 2011 - 10:21 PM
Edited by MrHappy, 04 December 2011 - 10:59 PM.
Posted 04 December 2011 - 10:25 PM
I'm not sure if the 4x more bioavailable sublingually is accurate, from personal/subjective experience. Seems a *lot* higher.
Edited by telight, 04 December 2011 - 10:26 PM.
Posted 04 December 2011 - 11:42 PM
Posted 05 December 2011 - 12:49 AM
Posted 05 December 2011 - 01:23 AM
Dunno. I've been using it sublingually today, at least (300 mg UMP, BID). Haven't really noticed anything.
Posted 05 December 2011 - 08:51 AM
Posted 05 December 2011 - 09:10 AM
Posted 05 December 2011 - 12:38 PM
Posted 05 December 2011 - 03:12 PM
Posted 05 December 2011 - 05:01 PM
Posted 05 December 2011 - 07:37 PM
Posted 05 December 2011 - 08:13 PM
I'm still waiting for my TAU. :( Apparently arriving next week - something about low stock. <chuckle>
I'll also be doing testing on subjective potency. If it's not as potent as we've read, next purchase will be a 1Kg tub of UMP from Alibaba or China directly. Probably followed by a lab test..
Posted 05 December 2011 - 10:06 PM
Edited by MrHappy, 05 December 2011 - 10:27 PM.
Posted 06 December 2011 - 12:56 AM
This review deals with the concept of sleep mechanism based on our uridine receptor theory. It is well established that uridine is one of the sleep-promoting substances, we have, therefore, synthesized new types of hypnotic compounds from oxopyrimidine nucleosides. Their mechanism of action in CNS depressant effects is elucidated based on the receptor theory. In this study, structure-activity relationship for CNS depressant properties, sleep-promoting effects, interaction with certain CNS receptors, and receptor binding assay of uridine derivatives as oxopyrimidine nucleoside were investigated. In the studies of structure-activity relationship of N3-substituted uridine, we found for the first time that both N3-benzyluridine and N3-phenacyluridine synthesized exhibited potent hypnotic activity (loss of righting reflex) by intracerebroventicular injection in mice. Moreover, certain derivatives of these compounds possessed synergistic effects with barbiturate and benzodiazepine, and decreased in spontaneous activity, motor incoordination, and antianxiety effects in mice. Especially, N3-phenacyluridine markedly enhanced pentobarbital- and diazepam-induced sleep by 6- and 70-fold, respectively. However, N3-benzyluracil and N3-phenacyluracil that have no ribose moiety did not possess any hypnotic activity, indicating specific effects of nucleoside derivatives. Effects of N3-benzyluridine on natural sleep in rats were thus examined. N3-Benzyluridine also possessed the sleep promoting effect assessed by electrocorticogram at the dose of 10 pmol. For elucidating the mechanism of action of N3-phenacyluridine, the interactions of this compound with benzodiazepine, GABA, 5-HT, or adenosine receptors were also investigated. Although the pharmacological activity of N3-phenacyluridine was high, the affinities to benzodiazepine, GABA, 5-HT, and adenosine receptors were quite low. [3H]N3-Phenacyluridine concentration-dependently bound to synaptic membrane prepared from the bovine brain. The Scatchard analysis revealed a single component of the binding site. This binding site is proposed here as a novel receptor called "uridine receptor" for hypnotic activity of the uridine derivatives. The rank order of the distribution of these specific binding sites was found to be striatum > thalamus > cerebral cortex > cerebellum > mid brain > medulla oblongata in the rat brain. In the metabolic study of N3-phenacyluridine, we found that this compound was exclusively metabolized to N3-(S)-(+)-alpha-hydroxy-beta-phenethyluridine, but not the ®- form, in mice. N3-(S)-(+)-alpha-Hydroxy-beta-phenylethyluridine possessed not only strong hypnotic activity but also a high affinity to the uridine receptor of synaptic membranes, while the ®-isomer was low in both activities. Racemic mixture was shown to be intermediate for pharmacological effects of the compounds. These studies which used ®- or (S)-isomer indicate that uridine binding site or uridine receptor, exists in the CNS and plays some role in sleep regulation in mammals as one of the triggering steps in inducing hypnotic activity. It is suggested that uridine is released from steps of nucleic acid-nucleic protein biosynthesis (catabolism), and reaches the binding sites in the areas of the brain which regulate natural sleep. The uridine dissociated from the receptor is then utilized for the synthesis of nucleic acid (anabolism). We propose here that the induction of sleep may be mediated by uridine through uridine receptor in the CNS, although the structure of uridine receptor is not yet elucidated.
Posted 06 December 2011 - 02:02 AM
Posted 06 December 2011 - 04:57 AM
Uridine for treating type I and type II bipolar disorder:
http://www.faqs.org/...app/20090054370
... apparently as a cure, too.. if I'm reading this correctly:
[0087]A general dosage is between 3 and 100 mg/kg/day, e.g., which can be 0.25 to 7 grams (e.g., 0.25, 0.5, or 1 grams) per patient per day. Oral tablets of triacetyl uridine can be used. The daily dosage is administered on an ongoing basis until symptoms subside.
Posted 06 December 2011 - 05:27 AM
Posted 06 December 2011 - 05:39 AM
Or possibly 10x less, sublingually.
(null)
Posted 06 December 2011 - 07:17 AM
Posted 06 December 2011 - 08:31 AM
Posted 06 December 2011 - 09:07 AM
http://www.lieberton...9/cap.2010.0054
2011:
Open-Label Uridine for Treatment of Depressed Adolescents with Bipolar Disorder
This report is an open-label case series of seven depressed adolescents with bipolar disorder treated with uridine for 6 weeks. Treatment response was measured with the Children's Depression Rating Scale-Revised and the Clinical Global Impressions scale. Uridine was associated with decreased depressive symptoms, and was well tolerated by study participants. Further systematic studies of uridine are warranted.
Posted 06 December 2011 - 09:59 AM
Look what I found
http://www.bioportfo...dolescents.html
Posted 06 December 2011 - 11:00 AM
Uridine for treating type I and type II bipolar disorder:
http://www.faqs.org/...app/20090054370
... apparently as a cure, too.. if I'm reading this correctly:
[0087]A general dosage is between 3 and 100 mg/kg/day, e.g., which can be 0.25 to 7 grams (e.g., 0.25, 0.5, or 1 grams) per patient per day. Oral tablets of triacetyl uridine can be used. The daily dosage is administered on an ongoing basis until symptoms subside.
Posted 06 December 2011 - 11:30 AM
Edited by JChief, 06 December 2011 - 11:37 AM.
Posted 06 December 2011 - 12:01 PM
Posted 06 December 2011 - 12:56 PM
Copy/paste sections of a reply to a PM I sent a couple of days ago-
Effects:
It's quite different, in that there is no 'buzz' or stimulant effect whatsoever. The most obvious effect is increased mental clarity, calmness, cognitive ability and recall. A single dose would have little appreciable effect.
It will also raise your levels of acetylcholine *without* robbing the lipid membranes.
What it does is gradually repair and enhance your brain on a daily basis, by significantly promoting neurogenesis - you create or repair neurons, dendrites and lipid membranes. This includes receptors as well.
The overall 'effect' is that you feel like yourself, but unimpeded - existing cognitive or emotional issues disappear over a week or so and you start feeling and being awesome. Your capacity to learn and retain information is noticably better. Particularly when you relax and stop trying to mentally compare your responses to pre-supplementing days, I found.
My wife was recovering from Zoloft withdrawal, which left her with occasional anxiety attacks and obsessive behaviour. That just got better and then stopped altogether. Essentially she appears to have have made peace with her problems, as they arose, and moved on. Her critical thinking has improved and she is making better decisions overall. Her scores playing online Scrabble have increased to the point where she is just destroying the other players. She was smart to begin with, but now she appears to be 'unshackled', if you like.
In short, it just makes you a better and more capable person.
Side effects noticed: none noticed
Withdrawal effects: none
Interaction with drugs: none that I've been able to find on pubmed or google, other than mediating side-effects from neuroleptics and antidepressants.
My daily morning regime is:
500mg of alpha-gpc choline
250mg of uridine-5'-monophosphate
1 berocca
Washing down:
4 capsules of flaxseed oil (I'm vegetarian)
1 vitamin E capsule
1 grape-seed extract capsule equiv 12000mg
My nightly regime is:
1 lecithin capsule 1200mg
1 grape-seed extract capsule
Occasionally a bacopa capsule, 2 hours before sleep. It makes me too sleepy to feel like sex, so not an 'every day' supplement.
I found 2 American suppliers that sell bulk powder through their websites and also through ebay. Superiornutraceuticals - uridine and nutrabiolabs - alpha-gpc. Quality has been good. Shipping has been very quick.
The bulk alpha-gpc is annoying to dispense. The uridine jar comes with a 250mg scoop, but since the uridine sticks like crazy, I leave the scoop out of the jar, to prevent wasting it. 1 scoop of uridine in the cup, 2 scoops of alpha-gpc, then add the water and berocca. Stir. Voila.
Be sure to start adding some extra study matter to your routine - there's no point having extra cognitive ability and not using it to improve your knowledge-base!
Posted 06 December 2011 - 08:08 PM
Posted 07 December 2011 - 03:03 AM
Greatly improved. Wasn't expecting or looking for that, either. Not sure which part of this combination is responsible, but it is welcome.
To clarify something from my earlier quoted post - the 'no-stimulant' effect was observed at a 250mg normal oral dose. 250mg, sublingually, is quite different - still not like caffeine, but vaguely similar to some of the more positive effects of adderall.
Posted 07 December 2011 - 04:39 AM
0 members, 36 guests, 0 anonymous users